Botulinum neurotoxin serotype D is poorly effective in humans: An in vivo electrophysiological study

被引：33

作者：

Eleopra, Roberto ^{[1
]}

Montecucco, Cesare ^{[2
,3
]}

Devigili, Grazia ^{[1
]}

Lettieri, Christian ^{[1
]}

Rinaldo, Sara ^{[1
]}

Verriello, Lorenzo ^{[1
]}

Pirazzini, Marco ^{[2
]}

Caccin, Paola ^{[2
]}

Rossetto, Ornella ^{[2
]}

机构：

[1] Univ Hosp S Maria Misericordia, Dept Neurol, I-33100 Udine, Italy

[2] Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy

[3] Univ Padua, CNR, Inst Neurosci, I-35100 Padua, Italy

来源：

CLINICAL NEUROPHYSIOLOGY | 2013年 / 124卷 / 05期

关键词：

Botulinum neurotoxins; Botulinum neurotoxin serotype D; Human and mouse neuromuscular junction; Rat primary neuronal cultures; Compound muscle action potential; BIOLOGICAL-ACTIVITY; STRUCTURAL-ANALYSIS; MOSAIC NEUROTOXIN; BINDING-SITES; TOXIN; TETANUS; ANTIBODIES; MEMBRANE; UNIQUE; IDENTIFICATION;

D O I：

10.1016/j.clinph.2012.11.004

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Objective: Botulinum neurotoxins act on nerve endings and block neurotransmitter release. Their potency is due to their enzymatic activity and high affinity binding to neurons. Botulinum toxin type A is used in the treatment of human diseases characterized by hyperactivity of peripheral cholinergic nerve terminals, but some patients are or become resistant to it. This can be overcome by using other botulinum toxins, and studies have been performed with different toxin serotypes. Botulinum neurotoxin type D has never been tested in humans in vivo, and, therefore, we investigated the action of this toxin in mouse and human muscles. Methods: Botulinum toxin type D potency was determined on mouse hemidiaphragm and on rat neuronal cultures. From these experiments, doses to be injected in human volunteers were decided. The compound muscle action potential of toxin-injected Extensor Digitorum Brevis muscle was measured at different times points after injection in human volunteers. Results: Botulinum toxin type D is poorly effective in inducing human skeletal muscle paralysis. Conclusions: Botulinum toxin type D is very potent in mice and almost ineffective in humans in vivo. Significance: The results shed new light on the mechanism of toxin type D binding to the neuronal surface receptors. (C) 2012 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

引用

页码：999 / 1004

页数：6

共 63 条

[1]

Anderson J, 2009, HANDBOOK OF TOXICOLOGY OF CHEMICAL WARFARE AGENTS, P407, DOI 10.1016/B978-012374484-5.00030-4

[2]

Aoki K R, 2001, J Neurol, V248 Suppl 1, P3

[3]

Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.3.CO

[4]

2-Y

[5] A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4 [J].

Arndt, Joseph W. ;

Jacobson, Mark J. ;

Abola, Enrique E. ;

Forsyth, Charles M. ;

Tepp, William H. ;

Marks, James D. ;

Johnson, Eric A. ;

Stevens, Raymond C. .

JOURNAL OF MOLECULAR BIOLOGY, 2006, 362 (04) :733-742

[6] SERUM IGG ANTIBODY TO GANGLIOSIDE GQ1B IS A POSSIBLE MARKER OF MILLER FISHER SYNDROME [J].

CHIBA, A ;

KUSUNOKI, S ;

SHIMIZU, T ;

KANAZAWA, I .

ANNALS OF NEUROLOGY, 1992, 31 (06) :677-679

[7] MYELIN GANGLIOSIDES IN VERTEBRATES [J].

COCHRAN, FB ;

YU, RK ;

LEDEEN, RW .

JOURNAL OF NEUROCHEMISTRY, 1982, 39 (03) :773-779

[8]

Coffield JA, 1997, J PHARMACOL EXP THER, V280, P1489

[9] Immunological aspects of Botox®, Dysport® and Myobloc™/NeuroBloc® [J].

Dressler, D ;

Hallett, M .

EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 :11-15

[10] Mouse diaphragm assay for detection of antibodies against botulinum toxin type B [J].

Dressler, D ;

Lange, M ;

Bigalke, H .

MOVEMENT DISORDERS, 2005, 20 (12) :1617-1619

← 1 2 3 4 5 6 7 →